Vertraagde tijd
OTC Markets
15:30:07 13-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
102
USD
|
+0,01%
|
|
+7,11%
|
+2,00%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
214.715
|
215.682
|
196.476
|
194.400
|
207.226
|
209.220
|
-
|
-
|
Bedrijfswaarde
1 |
230.615
|
240.182
|
204.667
|
203.434
|
219.237
|
221.659
|
220.562
|
214.802
|
K/w-verhouding
|
30,4
x
|
26,7
x
|
8,2
x
|
28,3
x
|
14,1
x
|
20
x
|
17,2
x
|
15,8
x
|
Dividendrendement
|
3,19%
|
3,56%
|
3,83%
|
3,87%
|
3,79%
|
3,52%
|
3,66%
|
3,84%
|
Marktkapitalisatie/omzet
|
4,53
x
|
4,43
x
|
3,81
x
|
3,85
x
|
4,56
x
|
4,27
x
|
4,12
x
|
4,08
x
|
Bedrijfswaarde/omzet
|
4,86
x
|
4,94
x
|
3,96
x
|
4,02
x
|
4,82
x
|
4,53
x
|
4,34
x
|
4,19
x
|
Bedrijfswaarde/EBITDA
|
14,6
x
|
14,3
x
|
11,2
x
|
10,9
x
|
12,2
x
|
11,5
x
|
10,7
x
|
10,2
x
|
Bedrijfswaarde/FCF
|
17,9
x
|
20,5
x
|
15,4
x
|
17
x
|
16,6
x
|
16
x
|
14,4
x
|
13,3
x
|
FCF Yield
|
5,58%
|
4,87%
|
6,49%
|
5,87%
|
6,01%
|
6,26%
|
6,95%
|
7,51%
|
Price to Book
|
3,87
x
|
3,78
x
|
2,9
x
|
3,23
x
|
4,42
x
|
4,59
x
|
4,59
x
|
4,29
x
|
Aantal aandelen (in duizenden)
|
2.264.608
|
2.274.506
|
2.237.092
|
2.150.980
|
2.055.460
|
2.040.406
|
-
|
-
|
Referentieprijs
2 |
94,81
|
94,83
|
87,83
|
90,38
|
100,8
|
102,5
|
102,5
|
102,5
|
Datum van publicatie
|
29-01-20
|
26-01-21
|
02-02-22
|
01-02-23
|
31-01-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
47.445
|
48.659
|
51.626
|
50.545
|
45.440
|
48.957
|
50.791
|
51.311
|
EBITDA
1 |
15.809
|
16.845
|
18.246
|
18.613
|
17.937
|
19.244
|
20.658
|
21.066
|
Bedrijfsresultaat (EBIT)
1 |
14.112
|
15.416
|
16.588
|
16.665
|
16.372
|
18.039
|
19.225
|
19.586
|
Operationele Marge
|
29,74%
|
31,68%
|
32,13%
|
32,97%
|
36,03%
|
36,85%
|
37,85%
|
38,17%
|
Resultaat voor belastingen (EBT)
1 |
8.940
|
9.878
|
26.137
|
8.371
|
9.123
|
13.202
|
14.628
|
15.181
|
Nettowinst (verlies)
1 |
7.147
|
8.072
|
24.021
|
6.955
|
14.854
|
10.423
|
11.918
|
12.805
|
Nettomarge
|
15,06%
|
16,59%
|
46,53%
|
13,76%
|
32,69%
|
21,29%
|
23,47%
|
24,96%
|
WPA
2 |
3,120
|
3,550
|
10,71
|
3,190
|
7,150
|
5,117
|
5,970
|
6,496
|
Free Cash Flow
1 |
12.875
|
11.691
|
13.282
|
11.945
|
13.179
|
13.866
|
15.320
|
16.129
|
FCF-marge
|
27,14%
|
24,03%
|
25,73%
|
23,63%
|
29%
|
28,32%
|
30,16%
|
31,43%
|
Kasstroomconversie (ebitda)
|
81,44%
|
69,4%
|
72,79%
|
64,18%
|
73,47%
|
72,06%
|
74,16%
|
76,57%
|
Kasstroomconversie (nettowinst)
|
180,15%
|
144,83%
|
55,29%
|
171,75%
|
88,72%
|
133,04%
|
128,54%
|
125,96%
|
Dividend per aandeel
2 |
3,025
|
3,375
|
3,360
|
3,500
|
3,823
|
3,611
|
3,749
|
3,937
|
Datum van publicatie
|
29-01-20
|
26-01-21
|
02-02-22
|
01-02-23
|
31-01-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
13.229
|
12.531
|
12.781
|
12.543
|
12.690
|
12.953
|
13.622
|
11.782
|
11.423
|
11.829
|
12.253
|
12.477
|
12.766
|
11.905
|
12.155
|
EBITDA
|
4.274
|
4.407
|
4.989
|
4.783
|
4.473
|
-
|
4.668
|
-
|
4.224
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
3.819
|
4.083
|
4.270
|
4.282
|
4.030
|
4.413
|
4.668
|
4.405
|
3.821
|
4.537
|
4.588
|
4.697
|
4.542
|
4.790
|
4.895
|
Operationele Marge
|
28,87%
|
32,58%
|
33,41%
|
34,14%
|
31,76%
|
34,07%
|
34,27%
|
37,39%
|
33,45%
|
38,35%
|
37,45%
|
37,64%
|
35,58%
|
40,24%
|
40,27%
|
Resultaat voor belastingen (EBT)
1 |
16.951
|
2.669
|
2.042
|
1.919
|
1.741
|
2.740
|
2.769
|
1.552
|
2.377
|
3.129
|
3.856
|
3.879
|
3.664
|
-
|
-
|
Nettowinst (verlies)
1 |
16.308
|
2.222
|
1.695
|
1.575
|
1.466
|
2.293
|
2.316
|
1.513
|
8.480
|
2.688
|
2.777
|
2.814
|
2.515
|
-
|
-
|
Nettomarge
|
123,27%
|
17,73%
|
13,26%
|
12,56%
|
11,55%
|
17,7%
|
17%
|
12,84%
|
74,24%
|
22,72%
|
22,66%
|
22,55%
|
19,7%
|
-
|
-
|
WPA
2 |
7,290
|
1,000
|
0,7700
|
0,7300
|
0,6900
|
1,090
|
1,110
|
0,7300
|
4,140
|
1,310
|
1,358
|
1,386
|
1,252
|
-
|
-
|
Dividend per aandeel
2 |
3,360
|
-
|
-
|
-
|
3,500
|
-
|
-
|
-
|
3,823
|
-
|
0,9539
|
0,9539
|
0,9539
|
1,019
|
1,019
|
Datum van publicatie
|
02-02-22
|
26-04-22
|
19-07-22
|
25-10-22
|
01-02-23
|
25-04-23
|
18-07-23
|
24-10-23
|
31-01-24
|
23-04-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
15.900
|
24.500
|
8.191
|
9.034
|
12.011
|
12.439
|
11.342
|
5.582
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,006
x
|
1,454
x
|
0,4489
x
|
0,4854
x
|
0,6696
x
|
0,6464
x
|
0,5491
x
|
0,265
x
|
Free Cash Flow
1 |
12.875
|
11.691
|
13.282
|
11.945
|
13.179
|
13.866
|
15.320
|
16.129
|
ROE (netto-inkomsten/eigen vermogen)
|
17,5%
|
23,5%
|
22,7%
|
21%
|
25,4%
|
32,4%
|
38%
|
37,4%
|
ROA (netto-inkomsten/totale activa)
|
8,89%
|
6,45%
|
10,9%
|
10,7%
|
12,4%
|
10,7%
|
12,8%
|
14,2%
|
Totale activa
1 |
80.393
|
125.215
|
221.201
|
64.915
|
120.082
|
96.977
|
93.123
|
90.092
|
Nettoactief per aandeel
2 |
24,50
|
25,10
|
30,30
|
28,00
|
22,80
|
22,30
|
22,30
|
23,90
|
Cashflow per aandeel
2 |
5,880
|
5,950
|
6,670
|
6,480
|
6,910
|
7,790
|
8,430
|
8,720
|
Capex
1 |
2.257
|
1.275
|
1.378
|
1.198
|
1.060
|
1.195
|
1.267
|
1.318
|
Capex/omzet
|
4,76%
|
2,62%
|
2,67%
|
2,37%
|
2,33%
|
2,44%
|
2,49%
|
2,57%
|
Datum van publicatie
|
29-01-20
|
26-01-21
|
02-02-22
|
01-02-23
|
31-01-24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
102,5
USD Gemiddelde koersdoel
108,5
USD Spread / Gemiddelde doel +5,80% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +29,98% | 682 mld. | | +30,54% | 586 mld. | | -3,52% | 364 mld. | | +18,59% | 327 mld. | | +4,07% | 285 mld. | | +16,74% | 240 mld. | | -8,55% | 203 mld. | | +7,09% | 165 mld. | | -1,22% | 161 mld. |
Farmaceutische producten - Andere
|